2026 Q3 Threat Report: Top Threats, Emerging Trends, and Stronger Defenses

Tools & Techniques

Browse cybersecurity tools, technology, and techniques through our infographic library for simplified cybersecurity insights.

Lyell Immunopharma Improves Cloud Security with Fidelis Security

Lyell Immunopharma is a South San Francisco-based, publicly traded cell therapy company (LYEL). Their T cell reprogramming technology focuses on the mastery of T cells to cure patients with solid tumors. They apply proprietary genetic and epigenetic reprogramming technology platforms to address barriers present in solid tumors in order to develop new medicines with improved, durable, and potentially curative clinical outcomes.

Filter by Product:

Select
  • Fidelis vs. Other Deception Technologies: The Complete Competitive Analysis

    Essential insights for security leaders choosing the right platform to...

    Read Tools
  • Why Switch from Honeypots to Deception

    Ready to Move Beyond Honeypots? See What Comes Next

    A quick reference infographic revealing how adaptive deception outpaces old-school...

    Read Tools
  • The Ultimate XDR Vendor Checklist

    Use our XDR vendor checklist to find a platform with...

    Read Tools
  • Cyber Threat Hunting Checklist Featured banner

    Become a Cyberwarrior: Your Essential Threat Hunting Checklist to Detect and Defeat Hidden Attacks

    Dive deep into the skills, process, and platforms needed for...

    Read Tools
  • covid-19 cybersecurity challenges

    Addressing Cybersecurity Risks of Remote Work Post-COVID-19

    Discover how cyber attackers exploit COVID-19 through phishing, ransomware, and...

    Read Tools
  • NDR Evolution Featured Banner

    The Evolution of Network Security – Network Detection and Response (NDR)

    Explore the evolution of deep network visibility, detection, and response...

    Read Tools
Beyond the Hype: Building an AI-Ready Security Operations Center

Join John Pirc and Paul Girardi to gain expert insights, practical strategies, and a fresh perspective on the evolving AI threat landscape.